The transcription factor Pitx3 is expressed selectively in midbrain dopaminergic neurons susceptible to

Kelvin C Luk1, Vladimir V Rymar, Pepijn van den Munckhof

  • 1Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada.

Journal of Neurochemistry
|January 22, 2013
PubMed

Insights

The transcription factor Pitx3 is crucial for midbrain dopaminergic neuron survival. Pitx3-dependent neurons are vulnerable to toxins, unlike resistant calbindin-positive neurons, explaining Parkinson

Area of Science:

  • Neuroscience
  • Genetics
  • Developmental Biology

Background:

  • The transcription factor Pitx3 is essential for midbrain dopaminergic (mDA) neuron survival.
  • Pitx3 deficiency in mice leads to mDA neuron loss and Parkinson's disease-like motor deficits.
  • Previous research indicated Pitx3's broad requirement for mDA neuron survival.

Purpose of the Study:

  • To investigate the specific roles of Pitx3 in different mDA neuron subpopulations.
  • To determine if Pitx3 is required for the survival of all mDA neurons or specific subsets.
  • To elucidate the relationship between Pitx3 expression, cell vulnerability, and Parkinson's disease pathology.

Main Methods:

  • Analysis of Pitx3-hypomorphic (aphakia) mice to identify spared mDA neuron subpopulations.
  • Immunohistochemical analysis for Pitx3 and calbindin-D28k expression in mDA neurons.
  • Cell-mapping studies in wild-type mice to determine Pitx3 expression patterns.
  • MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxin treatment in Pitx3-deficient and hemizygous mice to assess vulnerability.

Main Results:

  • Adult Pitx3-hypomorphic mice retain specific mDA neuron subpopulations, indicating Pitx3 is not universally required.
  • Surviving mDA neurons in aphakia mice predominantly express calbindin-D28k, a marker of toxin resistance.
  • Pitx3 is mainly expressed in the ventral substantia nigra (SN), a region vulnerable to neurotoxins.
  • Pitx3-expressing SN mDA neurons are preferentially lost after MPTP treatment.
  • Pitx3 hemizygosity increases SN mDA neuron sensitivity to MPTP.

Conclusions:

  • Midbrain dopaminergic neurons comprise distinct subpopulations with differential Pitx3 dependence and toxin vulnerability.
  • Calbindin-positive neurons are Pitx3-autonomous and MPTP-resistant.
  • Calbindin-negative neurons are Pitx3-dependent and vulnerable to toxic injury, likely corresponding to neurons lost in Parkinson's disease.
  • Impaired Pitx3 function enhances mDA neuron susceptibility to neurotoxic insults.
  • Pitx3 plays a critical role in the selective vulnerability of mDA neurons observed in Parkinson's disease.